Beyond China+1: Why Global Pharma Is Redesigning Its Fine-Chemical Supply Chain
For decades, pharmaceutical sourcing was largely driven by three questions: Can you make the molecule? Can you meet the specification? Can you deliver it at the right cost? Today, the fine-chemical supply chain is being shaped by another question: Can we depend on you? Geopolitical uncertainty, medicine shortages, concentration of upstream manufacturing, changing regulatory expectations …
Beyond China+1: Why Global Pharma Is Redesigning Its Fine-Chemical Supply Chain Read More »